Armstrong A, Campanati A, Iversen L, Praestegaard M, Estebaranz JLL. Treatment or Psoriasis with Calcipotriene and Betamethasone Dipropionate (CAL/BDP) Cream Showed Significantly Higher Proportion of Patients with an Absolute mPASI≤2 Compared to CAL/BDP Gel/Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s233. Available from: https://jofskin.org/33014/index.php/skin/article/view/2418